Positioning of Left Ventricular Pacing Lead Guided by Intracardiac Echocardiography with Vector Velocity Imaging During Cardiac Resynchronization Therapy Procedure

LV Lead Positioning Guided by ICE With Vector Velocity Imaging. Introduction: Intraoperative modality for “real‐time” left ventricular (LV) dyssynchrony quantification and optimal resynchronization is not established. This study determined the feasibility, safety, and efficacy of intracardiac echoca...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 22; no. 9; pp. 1034 - 1041
Main Authors BAI, RONG, DI BIASE, LUIGI, MOHANTY, PRASANT, HESSELSON, AARON B., DE RUVO, ERMENEGILDO, GALLAGHER, PETER L., ELAYI, CLAUDE S., MOHANTY, SANGHAMITRA, SANCHEZ, JAVIER E., BURKHARDT, J. DAVID, HORTON, RODNEY, GALLINGHOUSE, G. JOSEPH, BAILEY, SHANE M., ZAGRODZKY, JASON D., CANBY, ROBERT, MINATI, MONIA, PRICE, LARRY D., HUTCHINS, C. LYNN, MUIR, MELODY A., CALO', LEONARDO, NATALE, ANDREA, TOMASSONI, GERY F.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.09.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:LV Lead Positioning Guided by ICE With Vector Velocity Imaging. Introduction: Intraoperative modality for “real‐time” left ventricular (LV) dyssynchrony quantification and optimal resynchronization is not established. This study determined the feasibility, safety, and efficacy of intracardiac echocardiography (ICE), coupled with vector velocity imaging (VVI), to evaluate LV dyssynchrony and to guide LV lead placement at the time of cardiac resynchronization therapy (CRT) implant. Methods: One hundred and four consecutive heart failure patients undergoing ICE‐guided (Group 1, N = 50) or conventional (Group 2, N = 54) CRT implant were included in the study. For Group 1 patients, LV dyssynchrony and resynchronization were evaluated by VVI including visual algorithms and the maximum differences in time‐to‐peak (MD‐TTP) radial strain. Based on the findings, the final LV lead site was determined and optimal resynchronization was achieved. CRT responders were defined using standard criteria 6 months after implantation. Results: Both groups underwent CRT implant with no complications. In Group 1, intraprocedural optimal resynchronization by VVI including visual algorithms and MD‐TTP was a predictor discriminating CRT response with a sensitivity of 95% and specificity of 89%. Use of ICE/VVI increased number of and predicted CRT responders (82% in Group 1 vs 63% in Group 2; OR = 2.68, 95% CI 1.08–6.65, P = 0.03). Conclusion: ICE can be safely performed during CRT implantation. “Real‐time” VVI appears to be helpful in determining the final LV lead position and pacing mode that allow better intraprocedural resynchronization. VVI‐optimized acute resynchronization predicts CRT response and this approach is associated with higher number of CRT responders. (J Cardiovasc Electrophysiol, Vol. 22, pp. 1034‐1041, September 2011)
Bibliography:ark:/67375/WNG-3RQZB95X-Q
ArticleID:JCE2052
istex:7544CDD787F70479330CB149EA4A264C0D2A5194
Dr. Di Biase is a consultant for Hansen Medical and Biosense Webster. Dr. Hesselson received honoraria from or is a consultant for Medtronic, Boston Scientific, St. Jude Medical, Biotronik, and Biosense Webster; received royalty payments from Blackwell Futura; and is an advisory board member for Biosense Webster, Boston Scientific, and Proctor and Gamble. Dr. Gallagher received honoraria or is a consultant for Boston Scientific, Siemens, Stereotaxis, and St. Jude Medical, and is an advisory board member for Boston Scientific. Dr. Natale received compensation for belonging to the speakers’ bureau from Boston Scientific, Biosense Webster, and St. Jude Medical, and has received research grants from St. Jude Medical. Dr. Tomassoni received honoraria or is a consultant for Stereotaxis, Biosense Webster, Siemens, St. Jude Medical, Medtronic, and Boston Scientific, is an advisory board member for Stereotaxis, Biosense Webster, Siemens, St. Jude Medical, and has received research grants from Stereotaxis and Siemens.
Other authors: No disclosures.
Dr. Bai was supported from China by the Program for New Century Excellent Talents in University (NCET‐09‐0376), the National Natural Science Foundation (NSFC‐30700297), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SFR ROCS 2008‐101).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1045-3873
1540-8167
DOI:10.1111/j.1540-8167.2011.02052.x